Exploring the Modulatory Effect of the Dialyzer Membrane Choice on Hemodialysisassociated Thromboinflammation: a Prospective Randomized Cross-over Trial

NCT07682701 · clinicaltrials.gov ↗

NA

Phase

ACTIVE_NOT_RECRUITING

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Hemodialysis
End Stage Renal Disease (ESRD)
Hemodialysis Treatment
Thromboinflammation

Interventions

DEVICE: Use of a polysulfone membrane
DEVICE: Use of an asymmetric triacetate membrane
DEVICE: Use of a polymethyl methacrylate membrane

Sponsor

Universitair Ziekenhuis Brussel

Collaborators

[object Object]
[object Object]
[object Object]